<HTML><HEAD><TITLE>juvenile Gm1 gangliosidosis</TITLE>
<META NAME="GENERATOR" CONTENT="Microsoft FrontPage 6.0">
<style>
<!--
 li.MsoNormal
	{mso-style-parent:"";
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	margin-left:0in; margin-right:0in; margin-top:0in}
-->
</style>
</HEAD>
<BODY BACKGROUND="Graphics/Cheetah.jpg">
<p><font size="5" color="#FF00FF"><b>Juvenile Gm1 gangliosidosis</b></font></p>
<p><font size="4" face="Times New Roman" color="#0000FF">* </font>
<font face="Times New Roman" color="#CC3300" size="4">&#272;&#7883;nh ngh&#297;a</font><font size="4" face="Times New Roman" color="#0000FF">:</font></p>
<blockquote>
	<p><font color="#0000FF" size="4">+ R&#7889;i lo&#7841;n chuy&#7875;n hóa lipid &#7903; ng&#432;&#7901;i tr&#7867; 
	Gm1</font></p>
	<p><font size="4" color="#0000FF">+ R&#7889;i lo&#7841;n này v&#7899;i cái tên chung là:
	</font><font color="#0000FF" size="4">GM1 gangliosidosis v&#7899;i 3 th&#7875; khác 
	nhau:</font></p>
	<blockquote>
		<p><font color="#0000FF" size="4">- Th&#7875; 1: tr&#7867; s&#417; sinh</font></p>
		<p><font color="#0000FF" size="4">- Th&#7875; 2: x&#7843;y ra &#7903; ng&#432;&#7901;i tr&#7867;</font></p>
		<p><font color="#0000FF" size="4">- Th&#7875; 3: x&#7843;y ra &#7903; ng&#432;&#7901;i l&#7899;n</font></p>
	</blockquote>
	<p><font size="4" color="#0000FF">+ &#272;&#7885;c thêm:</font></p>
	<p><b><font color="#0000FF" size="4">Background</font></b></p>
	<p><font color="#0000FF" size="4">GM1 gangliosidosis is an autosomal 
	recessive lysosomal storage disorder characterized by the generalized 
	accumulation of GM1 ganglioside, oligosaccharides, and the 
	mucopolysaccharide keratan sulfate (and their derivatives). Deficiency of 
	the lysosomal hydrolase, acid b-galactosidase, causes GM1 gangliosidosis and 
	Morquio disease type B (ie, mucopolysaccharidosis type IVB). Three clinical 
	subtypes of GM1 gangliosidosis exist, classified by age of onset, as 
	follows: </font></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Infantile (type 1): The classic infantile 
		subtype combines the features of a neurolipidosis (ie, 
		neurodegeneration, macular cherry-red spots) with those of a 
		mucopolysaccharidosis (ie, visceromegaly, dysostosis multiplex, 
		coarsened facial features). This form of GM1 gangliosidosis most 
		frequently presents in early infancy and may be evident at birth. </font>
		</li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Juvenile (type 2): The juvenile subtype 
		is marked by a slightly later age of onset and clinical variability in 
		the classic physical features. </font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Adult (type 3): The adult subtype is 
		marked by normal early neurologic development with no physical stigmata 
		and subsequent development of a slowly progressive dementia with 
		parkinsonian features, extrapyramidal disease, and dystonia. </font>
		</li>
	</ul>
	<p><b><font color="#0000FF" size="4">Pathophysiology</font></b></p>
	<p><font color="#0000FF" size="4">Acid b-galactosidase is a lysosomal 
	hydrolase that catalyzes the removal of the terminal b-linked galactose from 
	glycoconjugates (eg, GM1 ganglioside), generating GM2 ganglioside. It also 
	functions to degrade other b-galactose–containing glycoconjugates, such as 
	keratan sulfate. Enzyme activity is markedly reduced in patients with GM1 
	gangliosidosis. Deficiency of acid b-galactosidase results in the 
	accumulation of glycoconjugates in body tissues and their excretion in 
	urine. GM1 ganglioside and its derivative asialo-GM1 ganglioside (GA1), 
	glycoprotein-derived oligosaccharides, and keratan sulfate are found at 
	elevated intracellular concentrations. </font></p>
	<p><font size="4" color="#0000FF">Gangliosides are normal components of cell 
	membranes, particularly neurons, and GM1 is the major ganglioside in the 
	vertebrate brain. Accumulation of toxic asialo- and lyso-compound GM1 
	ganglioside derivatives is believed to be neuropathic.</font></p>
	<p><b><font size="4" color="#0000FF">Frequency: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font color="#0000FF" size="4">In the US: GM1 gangliosidosis is a rare 
		disorder, and data concerning incidence are not widely available. </font>
		</li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font color="#0000FF" size="4">Internationally: An unusually high 
		incidence of 1 case per 3700 live births has been reported in the 
		population of Malta. </font></li>
	</ul>
	<p><b><font size="4" color="#0000FF">Mortality/Morbidity: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">The infantile form (type 1) typically 
		presents between birth and age 6 months with progressive organomegaly, 
		dysostosis multiplex, facial coarsening, and rapid neurologic 
		deterioration within the first year of life. Death usually occurs during 
		the second year of life because of infection (usually due to pneumonia 
		that results from recurrent aspiration) and cardiopulmonary failure.
		</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">The juvenile form (type 2) typically 
		presents at age 1-2 years with progressive psychomotor retardation. 
		Little visceromegaly and milder skeletal disease are present compared to 
		the infantile form. Death usually occurs before the second decade of 
		life. </font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">The adult form (type 3) typically 
		presents during childhood or adolescence as a slowly progressive 
		dementia with prominent parkinsonian features and extrapyramidal 
		disease, particularly dystonia. Marked phenotypic variability may occur. 
		Age at death may vary greatly. </font></li>
	</ul>
	<p><font color="#0000FF" size="4"><b>Race:</b></font></p>
	<p><font color="#0000FF" size="4">GM1 gangliosidosis is found in all races, 
	although specific alleles can be identified in certain ethnic groups. A 
	large number of Japanese patients with the adult form has been reported.
	</font></p>
	<p><font color="#0000FF" size="4"><b>Sex:</b> All 3 types of GM1 
	gangliosidosis are inherited as autosomal recessive traits and have equal 
	sex distributions. </font></p>
	<p><b><font size="4" color="#0000FF">Age: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">The infantile form (type 1) typically 
		presents from birth to age 6 months. </font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">The juvenile form (type 2) typically 
		presents in children aged 1-3 years. </font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">The adult form (type 3) typically 
		presents during childhood or adolescence. </font></li>
	</ul>
	<p><b><font size="4" color="#0000FF">History: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Infantile: In the most common infantile 
		form, coarse facial features, hepatosplenomegaly, generalized skeletal 
		dysplasia (dysostosis multiplex), macular cherry-red spots, and 
		developmental delay/arrest (followed by progressive neurologic 
		deterioration) usually occur within the first 6 months of life. 
		Nonimmune hydrops has been reported. An increased incidence of Mongolian 
		spots has also been reported. A wide spectrum of variability can exist 
		in the appearance and progression of the typical dysmorphic features. As 
		many as 50% of affected infants have a macular cherry-red spot.</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Juvenile: The juvenile form is 
		characterized by a later age of onset, less hepatosplenomegaly (if any), 
		fewer cherry-red spots (if any), dysmorphic features, or skeletal 
		changes (vertebral dysplasia may be detected radiographically).</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Adult: The adult form is characterized by 
		normal early neurologic development, with variable age of clinical 
		presentation. Slowly progressing dementia with parkinsonian features and 
		extrapyramidal disease is common. Intellectual impairment may be 
		initially absent or mild but progresses with time. Generalized dystonia 
		with speech and gait disturbance is the most frequently reported early 
		feature. Typically, no hepatosplenomegaly, cherry-red spots, dysmorphic 
		features, or skeletal changes are present aside from scoliosis (mild 
		vertebral changes may be revealed with radiography), but short stature 
		is common.</font></li>
	</ul>
	<p><b><font size="4" color="#0000FF">Physical: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Neurologic findings</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Developmental delay, arrest, and 
			regression</font></li>
		</ul>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Generalized hypotonia initially, 
			developing into spasticity </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Exaggerated startle response </font>
			</li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Hyperreflexia </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Seizures </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Extrapyramidal disease (adult 
			subtype) </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Generalized dystonia (adult subtype)
			</font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Ataxia (adult subtype) </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Dementia (adult subtype) </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Speech and swallowing disturbance 
			(adult subtype)</font></li>
		</ul>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Ophthalmologic findings</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Macular cherry-red spots </font>
			<ul type="square" style="margin-bottom: 0in">
				<li class="MsoNormal" style="color: black">
				<font size="4" color="#0000FF">Present in as many as 50% of 
				affected infants </font></li>
				<li class="MsoNormal" style="color: black">
				<font size="4" color="#0000FF">May be found in other genetic 
				disorders (eg, mucolipidosis type I, Niemann-Pick disease, 
				Krabbe disease, Tay-Sachs disease)</font></li>
			</ul>
			</li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Optic atrophy </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Corneal clouding</font></li>
		</ul>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Dysmorphic features</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Frontal bossing </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Depressed nasal bridge and broad 
			nasal tip </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Large low-set ears </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Long philtrum </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Gingival hypertrophy and macroglossia</font></li>
		</ul>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Coarse skin</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Hirsutism</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Cardiovascular - Dilated and/or 
		hypertrophic cardiomyopathy, valvulopathy</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Abdomen</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Hepatosplenomegaly </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Inguinal hernia</font></li>
		</ul>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Skeletal abnormalities</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Lumbar gibbus deformity and 
			kyphoscoliosis </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Dysostosis multiplex </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Broad hands and feet </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Brachydactyly </font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Joint contractures</font></li>
		</ul>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Angiokeratoma corporis diffusum (reported 
		infrequently)</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Hydrops fetalis (has been reported)</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Prominent dermal melanocytosis (Mongolian 
		spots) (have been reported in a number of cases)</font></li>
	</ul>
	<p><b><font size="4" color="#0000FF">Causes: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">All 3 forms of GM1 gangliosidosis are 
		caused by deficiency in acid b-galactosidase activity.</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">GM1 gangliosidosis is an autosomal 
		recessive disease; therefore, affected individuals inherit 2 copies of 
		the nonfunctioning gene. Carriers (ie, individuals with 1 functioning 
		and 1 nonfunctioning gene) have no clinical manifestations.</font></li>
	</ul>
	<ul type="disc" style="margin-bottom: 0in">
		<ul type="circle" style="margin-bottom: 0in">
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">The gene has been isolated and is 
			located on chromosome band 3p21.33. Various types of mutations have 
			been identified in the acid b-galactosidase gene, including 
			missense/nonsense, duplication/insertion, and splice site 
			abnormalities.</font></li>
			<li class="MsoNormal" style="color: black">
			<font size="4" color="#0000FF">Genotype and phenotype correlations 
			are being delineated to provide a molecular explanation for clinical 
			variability. Presumably, the amount of residual enzyme activity 
			determines disease subtype and severity</font></li>
		</ul>
	</ul>
	<p><b><font size="4" color="#0000FF">Medical Care: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Currently, no effective medical treatment 
		is available for the underlying disorder. Bone marrow transplantation 
		was successful in an individual with infantile/juvenile GM1 
		gangliosidosis; however, no long-term benefit was reported. 
		Presymptomatic cord-blood hematopoietic stem-cell transplantation has 
		been advocated by some as a possible treatment because of success in 
		other lysosomal storage disorders.</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Symptomatic treatment for some neurologic 
		sequelae is available but does not significantly alter the clinical 
		course.</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Active research in the areas of enzyme 
		replacement and gene therapy for GM1 gangliosidosis is ongoing but has 
		not advanced to human trials.</font></li>
	</ul>
	<p><b><font size="4" color="#0000FF">Consultations: </font></b></p>
	<ul type="disc" style="margin-bottom: 0in">
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Clinical geneticist - For initial 
		evaluation and diagnosis, to counsel families regarding recurrence risk, 
		and to help provide prenatal testing for future pregnancies</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Neurologist - For symptomatic therapy of 
		multiple neurologic sequelae</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Cardiologist - To evaluate for 
		cardiomyopathy</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Orthopedist - To evaluate for dysostosis 
		multiplex</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Ophthalmologist - To evaluate for ocular 
		stigmata</font></li>
		<li class="MsoNormal" style="color: black">
		<font size="4" color="#0000FF">Otolaryngologist and audiologist - To 
		assess for hearing loss</font></li>
	</ul>
	<p><font color="#0000FF" size="4"><b>Diet:</b></font></p>
	<p><font color="#0000FF" size="4">No specific dietary modifications have 
	been shown to significantly alter the clinical course. Infants ultimately 
	may require tube feeding to provide adequate intake of energy; however, 
	nutritional support does not change the disease course, and some families 
	may choose to forgo invasive alimentation procedures.</font></p>
	<p><a name="section~treatment"><font color="#0000FF" size="4">Activity:</font></a></p>
	<p><font size="4" color="#0000FF">Neurologic and orthopedic sequelae may 
	preclude adequate physical activity, and patients may benefit from physical 
	and occupation therapy.</font></p>
	<p>&nbsp;</p>
	<p>&nbsp;</p>
</blockquote></BODY></HTML>